Community Pharmacy Trans Health Medicines Stockholding - Sefton

The NHS Cheshire and Merseyside Integrated Care Board has completed the procurement process for the "Community Pharmacy Trans Health Medicines Stockholding - Sefton" project. This contract, classified under the health services industry category, was awarded through a Provider Selection Regime. The aim is to ensure that pharmacies in Sefton maintain a stock of medicines used for gender dysphoria treatments, thus supporting the health and well-being of transgender individuals.

The contract, which commenced on 1st April 2025 and ends on 31st March 2026, was initiated via a limited procurement method, specifically a direct award to selected Sefton pharmacies, all within the UKD73 region. The contract was signed on 19th November 2024 and marked an active status alongside a reported nominal activity-based funding model. This tender presents significant opportunities for businesses, particularly those operating in the healthcare services sector, such as community pharmacies.

Since the contract focuses on timely access to medications and supporting transgender health and well-being, pharmacies with robust supply chain capabilities and a commitment to inclusive healthcare services are well-suited to take part. Large businesses like ASDA Stores Limited, already awarded and actively engaged, serve as an example of the scale and capability combination needed to successfully compete for work within such projects. This contract may also encourage smaller pharmacies to enhance their service scopes and participate in future bids under similar procurement frameworks.